文献速递慢病管理预防保健、筛查与疫苗

医师-药师协作对糖尿病结局与医疗使用的影响

Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use.
PubMed 文献 · J Am Board Fam Med · 2020-01-01

该回顾性观察队列研究在Ascension Medical Group Via Christi比较医师-药师协作管理与医师单独管理对385例糖尿病患者12个月HbA1c变化的影响。协作组HbA1c平均下降1.75%,常规组下降0.16%(P < .0001),协作组急诊就诊和住院显著减少并估算节省633,015美元。结论认为协作管理改善糖尿病结局并大幅降低医疗使用相关成本。

要点

  • 协作组12个月HbA1c平均下降1.75%,常规组下降0.16%(P < .0001)。
  • 协作组总胆固醇、甘油三酯下降及PPSV23疫苗接种增加显著。
  • 协作组急诊就诊与住院显著减少,估算总节省633,015美元。

核心结论

  • 在初级保健中,医师与药师协作管理糖尿病与改善糖尿病结局相关,并因医疗使用减少而大幅降低成本。

研究设计与样本

  • 回顾性观察队列研究,2016年1月1日至2018年6月30月在Ascension Medical Group Via Christi, P.A.开展。
  • 385例糖尿病患者接受医师-药师协作管理,采用最近邻匹配与医师单独管理的相似患者比较。
  • 主要结局为协作组与常规组12个月时HbA1c变化。

主要发现

  • 协作组HbA1c平均下降1.75%,常规组下降0.16%(P < .0001)。
  • 随访时常规组HbA1c低于8%的患者数更多(P = .0049)。
  • 协作组总胆固醇下降(P = .0023)、甘油三酯下降(P = .0016)、PPSV23肺炎球菌疫苗接种增加(P = .0255)。
  • 常规组PCV13肺炎球菌疫苗接种增加(P = .0075)。
  • 协作组急诊就诊(P = .0162)与住院(P = .0225)显著减少,估算总节省633,015美元。

关键数值与推荐

  • 协作组HbA1c平均变化为下降1.75%,常规组为下降0.16%(P < .0001)。
  • 协作组总胆固醇下降P = .0023,甘油三酯下降P = .0016,PPSV23疫苗接种增加P = .0255。
  • 常规组HbA1c低于8%的患者数更多P = .0049,PCV13疫苗接种增加P = .0075。
  • 协作组急诊就诊减少P = .0162,住院减少P = .0225,估算总节省633,015美元。

临床怎么用

  • 在初级保健中可考虑医师-药师协作模式管理糖尿病患者,以改善HbA1c、血脂和部分疫苗接种并减少急诊与住院使用。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of physician-pharmacist collaboration for disease-state management on diabetes outcomes in primary care by comparing outcomes between physician-managed care and pharmacist collaborative care. METHODS: A retrospective, observational cohort study was conducted at Ascension Medical Group Via Christi, P.A. from January 1, 2016 to June 30, 2018. Health outcomes were analyzed in 385 patients with diabetes mellitus collaboratively managed by a physician and pharmacist (collaborative care group). Similar patients managed by physician only (usual care group) were matched to the collaborative care group using nearest neighbor matching. The primary outcome compared glycosylated hemoglobin (HbA1c) change between collaborative care and usual care groups at 12 months. RESULTS: The mean change in HbA1c decreased by 1.75% in the collaborative care group and 0.16% in the usual care group (P < .0001). The usual care group had a larger number of patients with HbA1c less than 8% at follow-up (P = .0049). Additional outcomes included decrease in total cholesterol (P = .0023), triglycerides (P = .0016), and an increase in PPSV23 pneumococcal vaccinations (P = .0255) in the collaborative care group. The usual care group had an increase in PCV13 pneumococcal vaccinations (P = .0075). Both emergency department visits (P = .0162) and hospitalizations (P = .0225) decreased significantly in the collaborative care group, estimating total savings of $633,015. CONCLUSIONS: The collaboration of pharmacists and physicians in the primary care setting is associated with improved diabetes outcomes and substantially reduces costs related to decreased health care use.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Norton MC, Haftman ME, Buzzard LN, et al. Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use. J Am Board Fam Med. 2020. PMID: 32989069. doi:10.3122/jabfm.2020.05.200044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。